查看購物車
  • English
  • Japanese
全球獸醫即時診斷（PoC）市場（至 2031 年）：按產品（耗材和設備）、技術（免疫診斷和分子診斷（等溫擴增、PCR、CRISPR））和動物類型（伴侶動物、牲畜、家禽）分類
市場調查報告書
商品編碼
2051999

全球獸醫即時診斷（PoC）市場（至 2031 年）：按產品（耗材和設備）、技術（免疫診斷和分子診斷（等溫擴增、PCR、CRISPR））和動物類型（伴侶動物、牲畜、家禽）分類

Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031
出版日期: | 出版商: MarketsandMarkets | 英文 373 Pages | 訂單完成後即時交付

價格

預計獸醫概念驗證 (PoC) 診斷市場將從 2026 年的 11.9 億美元成長到 2031 年的 17.2 億美元，複合年成長率為 7.7%。

推動這一成長的幾個關鍵因素塑造了快速獸醫診斷、分散式檢查和即時動物健康管理的未來。

調查範圍
調查期 2026-2031
基準年 2025
預測期 2026-2031
單元 金額（美元）
部分 產品、技術、動物種類、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

獸醫概念驗證（PoC）診斷市場的主要驅動力是伴侶動物和牲畜獸醫實踐中對疾病識別的日益重視，這推動了對快速臨床決策的需求。隨著寵物飼養和畜牧業集約化程度的提高，對快速臨床決策的需求至關重要，促使獸醫和動物保健機構優先考慮早期檢測和定期健康監測，從而減輕疾病負擔並改善治療管理。因此，動物醫院、農場和第一線獸醫擴大採用POC設備，例如快速免疫檢測、攜帶式分子診斷系統和手持分析儀，以快速識別疾病。

獸醫即時診斷市場-IMG1

另一個主要促進因素是人們日益關注動物健康預防、生物安全以及通用感染疾病和具有重要經濟意義的疾病的管理。各國政府、獸醫協會和養殖戶越來越重視疾病監測，以減少疾病爆發，並保障食品安全和公共衛生。這推動了對概念驗證（PoC）檢測的需求，旨在快速檢測疾病並輔助治療決策。

此外，儘管目前的概念驗證（PoC）診斷市場仍在發展中，但診斷技術的進步，特別是診斷設備的微型化和便攜性提升、等溫擴增技術以及整合數位平台的出現，正在提高PoC診斷工具的性能和實用性。盒式系統、即用型診斷試劑盒和聯網診斷設備的開發可望顯著縮短檢測時間並實現流程自動化，從而拓展PoC診斷的應用範圍。

按動物類型分類，預計伴侶動物在預測期內將錄得更高的複合年成長率。

由於全球寵物數量不斷成長、寵物「擬人化」趨勢日益明顯以及寵物主人在高級獸醫護理方面的支出增加，預計伴侶動物市場將呈現更高的成長率。寵物飼主越來越需要快速的診所內診斷，以便及早發現疾病並即時做出治療決策，這推動了獸醫醫院對即時診斷（PoC）技術的應用。此外，人們對預防保健意識的提高、就診頻率的增加以及專為伴侶動物量身定做的先進、便捷的診斷解決方案的普及，都進一步加速了該領域的成長。

按技術分類，預計到 2025 年，免疫診斷領域將佔據最大的市場佔有率。

到2025年，免疫診斷領域將在獸醫概念驗證（PoC）診斷市場佔據主導地位，這主要得益於快速、易於實施的檢測方法（包括橫向流動化驗和基於酶聯免疫吸附試驗（ELISA）的試劑盒）的廣泛應用。這些檢測方法常用於檢測伴侶動物和家畜的感染疾病、寄生蟲和生物標記物，已成為日常獸醫護理的必備手段。快速出結果、成本效益高、樣本製備簡便、無需複雜基礎設施即可在診所和現場使用等優勢，推動了免疫診斷技術的快速普及，使其成為市場中的一個重要細分領域。

在預測期內，亞太地區預計將錄得最高的成長率。

亞太地區獸醫概念驗證（PoC）診斷市場成長最快。這主要歸功於該地區新興經濟體畜牧業產量增加、寵物飼養量上升以及動物健康管理意識的提高。除了許多新興國家寵物飼養量的成長外，獸醫基礎設施的擴建以及政府在疾病監測和控制方面的舉措，也推動了攜帶式快速診斷產品在臨床和農場中的應用。感染疾病和通用感染疾病率的上升，以及全球和區域領先企業加大投資，正在推動攜帶式、易用型獸醫PoC診斷設備的廣泛應用。

本報告考察了全球獸醫概念驗證 (PoC) 診斷市場，提供了市場概述、影響市場成長的各種因素分析、技術和專利趨勢、法律制度、案例研究、歷史和預測的市場規模、按細分市場、地區/主要國家/地區進行的詳細分析、競爭格局以及主要公司的概況。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
    • 任務
  • 未滿足的需求和閒置頻段
  • 與相關市場和不同產業相關的跨領域機遇
  • 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

  • 波特五力分析
  • 宏觀經濟展望
    • GDP趨勢與預測
    • 全球醫療保健產業趨勢
    • 全球動物用藥品產業的趨勢
  • 價值鏈分析
  • 生態系分析
  • 價格分析
  • 貿易分析
  • 2026-2027 年主要會議和活動
  • 影響客戶業務的趨勢/顛覆性因素
  • 投資和資金籌措場景
  • 案例研究分析
  • 美國關稅對獸醫即時診斷市場的影響

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

  • 關鍵技術/新興技術
    • 基於CRISPR的分子診斷
    • 等溫擴增及紙基LAMP方法
  • 互補技術
    • 微流體和實驗室晶片裝置
    • 基於生物感測器的診斷系統
  • 鄰近技術
    • 人工智慧和機器學習
    • 穿戴式生物感測器和遠端監控設備
  • 技術/產品藍圖
    • 短期（2025-2027）
    • 中期計劃（2028-2030年）
    • 長期（2030 年後）
  • 專利分析
  • 未來應用
    • 在絮凝層進行精確的疾病預測
    • 一款緊湊、完全整合的農場分子診斷平台。
    • 獸醫多重疾病和症候群診斷組合
    • 利用智慧生物感測器進行即時健康監測
  • 人工智慧/生成式人工智慧對獸醫即時診斷市場的影響

第7章：監理情勢與永續性舉措

  • 當地法規和合規性
  • 對永續性的承諾

第8章：顧客趨勢與購買行為

  • 客戶趨勢和購買行為
  • 採購過程中的關鍵相關利益者及其評估標準
  • 實施障礙和內部挑戰
  • 市場盈利

第9章 獸醫即時診斷市場：依產品分類

  • 消耗品
  • 裝置

第10章：獸醫即時診斷市場：以動物類型分類

  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 其他
  • 家畜
    • 牛
    • 豬
    • 家禽
    • 其他

第11章 獸醫即時診斷市場：依技術分類

  • 免疫診斷
  • 分子診斷
    • 基於PCR的
    • 等溫擴增
    • CRISPR 基礎
  • 其他

第12章 獸醫即時診斷市場：依地區分類

  • 北美洲
    • 宏觀經濟展望
    • 銷售分析：按產品分類
    • 美國
    • 加拿大
  • 歐洲
    • 宏觀經濟展望
    • 銷售分析：按產品分類
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 波蘭
    • 瑞典
    • 其他
  • 亞太地區
    • 宏觀經濟展望
    • 銷售分析：按產品分類
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 紐西蘭
    • 泰國
    • 其他
  • 拉丁美洲
    • 宏觀經濟展望
    • 銷售分析：按產品分類
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東和非洲
    • 宏觀經濟展望
    • 銷售分析：按產品分類
    • 海灣合作理事會國家
    • 其他

第13章 競爭格局

  • 概述
  • 主要公司/主要企業的競爭策略
  • 收入分析
  • 市佔率分析
  • 企業估值矩陣：主要公司
  • 公司估值矩陣：新創企業/中小企業
  • 品牌/產品對比
  • 主要公司的研發支出
  • 企業估值和財務指標
  • 競爭格局

第14章：公司簡介

  • 大公司
    • IDEXX LABORATORIES, INC.
    • ZOETIS SERVICES LLC
    • THERMO FISHER SCIENTIFIC INC.
    • ANTECH DIAGNOSTICS, INC.
    • BIONOTE
    • INNOVATIVE DIAGNOSTICS
    • BIOMERIEUX
    • INDICAL BIOSCIENCE GMBH
    • VIRBAC
    • MEGACOR DIAGNOSTIK GMBH
    • BIOGAL
    • RING BIOTECHNOLOGY CO., LTD.
    • AGROLABO SPA
    • ENALEES
    • BIOPANDA REAGENTS LTD
  • 其他公司
    • FASSISI, GMBH
    • SKYER, INC.
    • GOLD STANDARD DIAGNOSTICS
    • BIO-X DIAGNOSTICS SA
    • AFFIGEN INC.
    • ALVEO TECHNOLOGIES
    • FLUXERGY INC.
    • WOODLEY EQUIPMENT COMPANY LTD
    • UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
    • CORIS BIOCONCEPT

第15章：調查方法

第16章附錄

Product Code: MD 7656

The veterinary PoC diagnostics market is expected to grow from USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. This growth is driven by several key factors shaping the future of rapid veterinary diagnostics, decentralized testing, and real-time animal health management.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsPRODUCT, TECHNOLOGY ANIMAL TYPE, REGION
Regions coveredNorth America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa,

The veterinary PoC diagnostics market is primarily driven by increasing focus on disease identification at the point of care in companion and farm animals, fueling the need for rapid clinical decision-making. The growing trend of pet ownership and livestock intensification is pushing veterinarians and animal health service providers to emphasize early detection and regular health monitoring, helping them reduce the disease burden and improve treatment management. Consequently, veterinary clinics, farms and field veterinarians are increasingly employing point-of-care instruments such as rapid immunoassays, portable molecular systems, and handheld analyzers for rapid disease identification.

Veterinary PoC Diagnostics Market - IMG1

Another key driver is the growing focus on animal health prevention, biosecurity and management of zoonotic and economically important diseases. Governments, veterinary associations, and animal owners are placing greater focus on disease monitoring and surveillance to reduce the number of disease outbreaks and safeguard food safety and public health. This is increasing the demand for PoC testing for rapid disease detection and treatment decision-making.

In addition, while the current PoC diagnostic market is still in development, improvements in diagnostic technology, in particular smaller and more portable diagnostic devices, isothermal amplification techniques, and integrated digital platforms, are improving the potency and viability of PoC diagnostic tools. Developments including cartridge-based approaches, ready-to-use diagnostic kits, and connected diagnostic devices will greatly reduce testing times, automate processes, and make the wider use of PoC diagnostics more feasible.

By animal type, companion animals to record higher CAGR during forecast period

The companion animals segment is expected to witness a higher growth rate in the veterinary PoC diagnostics market due to the rising global pet population and increasing humanization of pets, leading to higher spending on advanced veterinary care. Pet owners are increasingly demanding rapid, in-clinic diagnostics for early disease detection and immediate treatment decisions, driving adoption of PoC technologies in veterinary clinics. Additionally, greater awareness of preventive healthcare, frequent veterinary visits, and the availability of advanced, user-friendly diagnostic solutions tailored for companion animals are further accelerating growth in this segment.

By technology, immunodiagnostics segment accounted for largest market share in 2025

In 2025, the immunodiagnostics segment dominated the veterinary PoC diagnostics market due to its widespread use in rapid, easy-to-perform testing formats such as lateral flow assays and ELISA-based kits. These tests are commonly used to detect infectious diseases, parasites, and biomarkers across both companion and livestock animals, making them integral to routine veterinary practice. Their advantages, including quick turnaround time, cost-effectiveness, minimal sample preparation, and suitability for in-clinic and field settings without advanced infrastructure, drive high adoption volumes and make immunodiagnostics the dominant segment in the market.

Asia Pacific to witness highest growth rate during forecast period

The Asia Pacific region is growing at the fastest rate in the veterinary PoC diagnostics market. The main reason for this is due to rising livestock production, pet ownership, and awareness of animal health management in emerging countries of the region. Pet adoption is increasing in many emerging nations, coupled with the rising use of portable, rapid diagnostic products in clinical and farm settings due to expanding veterinary infrastructure and government initiatives for disease surveillance and control. The growing incidence of infectious and zoonotic diseases and an increase in investments by global and regional players are leading to the wide adoption of portable, user-friendly veterinary PoC diagnostics.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
  • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
  • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Note: C-level executives include CEOs, COOs, CTOs, and VPs.

Other designations include sales, marketing, and product managers.

Breakdown of demand-side primary interviews:

  • By End User: Veterinary Hospitals & Clinics (50%), Homecare Settings (35%), Other End Users (15%)

By Designation: Veterinarians/Veterinary Practitioners (47%), Veterinary Clinics or Hospital Directors/Owners (22%), Livestock Farm Managers/Animal Health Managers (15%), and Others (16%)

  • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Note: Other end users include academic and research institutes, livestock farm owners, and animal welfare organizations.

Note: Other designations include laboratory technicians, practice managers, procurement officers, and academic researchers.

Research Coverage

The market study covers the veterinary PoC diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

  • Analysis of key drivers (rising demand for rapid, on-site diagnosis and immediate clinical decision-making, increasing pet ownership and intensification of livestock production), restraints (limited sensitivity/accuracy compared to centralized laboratory testing in some cases, high cost of advanced PoC devices and limited adoption in low-income regions), opportunities (technological advancements in portable molecular diagnostics and biosensors, growing adoption in emerging markets with expanding veterinary infrastructure), and challenges (lack of standardization and regulatory variations across regions, limited skilled professionals for proper use and interpretation of PoC tests) influencing the growth of the veterinary PoC diagnostics market
  • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the veterinary PoC diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets by analyzing the markets for various types of PoC diagnostic products across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary PoC diagnostics market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary PoC diagnostics market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNIT CONSIDERED
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN VETERINARY POC DIAGNOSTICS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 VETERINARY POC DIAGNOSTICS MARKET OVERVIEW
  • 3.2 VETERINARY POC DIAGNOSTICS MARKET IN ASIA PACIFIC, BY PRODUCT AND COUNTRY
  • 3.3 VETERINARY POC DIAGNOSTICS MARKET: REGIONAL MIX
  • 3.4 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.5 VETERINARY POC DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising incidence of transboundary and endemic diseases
      • 4.2.1.2 Increasing demand for animal-derived food products
      • 4.2.1.3 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms
      • 4.2.1.4 Growth in companion animal population
      • 4.2.1.5 Rising demand for pet insurance and growing animal health expenditure
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Rising pet care costs
      • 4.2.2.2 High cost of veterinary diagnostic tests
      • 4.2.2.3 Limited diagnostic infrastructure in emerging economies
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Integration of AI & ML in veterinary PoC diagnostics
      • 4.2.3.2 Expansion of rapid PoC and portable on-farm diagnostic solutions
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Rapid mutation and strain variability of viral pathogens
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
    • 4.5.1 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023-2025
      • 5.5.1.1 Pricing trend of veterinary PoC diagnostic products, by key player, 2023-2025
    • 5.5.2 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023-2025
      • 5.5.2.1 Pricing trend of PCR kits, by region, 2023-2025
      • 5.5.2.2 Pricing trend of immunodiagnostic veterinary POC products, by region, 2023-2025
  • 5.6 TRADE ANALYSIS
    • 5.6.1 TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS
      • 5.6.1.1 Country-wise import data for HS code 3822-compliant products, 2021-2025
      • 5.6.1.2 Country-wise export data for HS code 3822-compliant products, 2021-2025
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
    • 5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
    • 5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION
  • 5.11 IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRY/REGION
    • 5.11.5 IMPACT ON END USERS
      • 5.11.5.1 Veterinary hospitals & clinics
      • 5.11.5.2 Livestock producers & animal health networks
      • 5.11.5.3 Home care settings
      • 5.11.5.4 Other end users (mobile veterinary service providers, animal shelters, NGOs)

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY/EMERGING TECHNOLOGIES
    • 6.1.1 CRISPR-BASED MOLECULAR DIAGNOSTICS
    • 6.1.2 ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 MICROFLUIDICS & LAB-ON-A-CHIP DEVICES
    • 6.2.2 BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 AI & MACHINE LEARNING
    • 6.3.2 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
    • 6.4.1 NEAR TERM (2025-2027)
    • 6.4.2 MID TERM (2028-2030)
    • 6.4.3 LONG TERM (2030+)
  • 6.5 PATENT ANALYSIS
    • 6.5.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
    • 6.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION
    • 6.6.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS
    • 6.6.3 MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS
    • 6.6.4 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING
  • 6.7 IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET
    • 6.7.1 INTRODUCTION
    • 6.7.2 MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM
    • 6.7.3 AI USE CASES
    • 6.7.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY ANALYSIS
    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
    • 7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
    • 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
    • 8.1.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
    • 8.3.1 UNMET NEEDS OF VARIOUS END USERS
  • 8.4 MARKET PROFITABILITY

9 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 CONSUMABLES
    • 9.2.1 INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND
    • 9.2.2 GLOBAL VOLUME ANALYSIS OF CONSUMABLES, 2024-2031 (THOUSAND UNITS)
  • 9.3 INSTRUMENTS
    • 9.3.1 SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH
    • 9.3.2 GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024-2031 (THOUSAND UNITS)

10 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE

  • 10.1 INTRODUCTION
  • 10.2 COMPANION ANIMALS
    • 10.2.1 GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH
    • 10.2.2 DOG
      • 10.2.2.1 Increasing prevalence of canine infectious diseases to support rapid adoption of veterinary care
    • 10.2.3 CAT
      • 10.2.3.1 Growing awareness of feline infectious diseases to fuel market growth
    • 10.2.4 HORSE
      • 10.2.4.1 Need to prevent vertical pathogen transmission to stimulate use of extensive PCR surveillance solutions
    • 10.2.5 OTHER COMPANION ANIMALS
  • 10.3 LIVESTOCK
    • 10.3.1 SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS
    • 10.3.2 CATTLE
      • 10.3.2.1 Increasing focus on improving milk quality, herd productivity, and biosecurity management to drive demand
    • 10.3.3 PIG
      • 10.3.3.1 Growing swine disease outbreaks to accelerate diagnostic utilization
    • 10.3.4 POULTRY
      • 10.3.4.1 Rrising concerns regarding zoonotic disease transmission to spur demand
    • 10.3.5 OTHER LIVESTOCK

11 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 11.1 INTRODUCTION
  • 11.2 IMMUNODIAGNOSTICS
    • 11.2.1 PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH
  • 11.3 MOLECULAR DIAGNOSTICS
    • 11.3.1 PCR-BASED
      • 11.3.1.1 Increasing use of portable and multiplex PCR platforms to propel market
    • 11.3.2 ISOTHERMAL AMPLIFICATION
      • 11.3.2.1 Demand for rapid and low-infrastructure molecular testing to accelerate adoption
    • 11.3.3 CRISPR-BASED
      • 11.3.3.1 Emerging next-generation pathogen detection technologies to create growth potential
  • 11.4 OTHER TECHNOLOGIES

12 VETERINARY POC DIAGNOSTICS MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 12.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
    • 12.2.3 US
      • 12.2.3.1 High veterinary healthcare expenditure to drive market
    • 12.2.4 CANADA
      • 12.2.4.1 Growing pet adoption to drive market
  • 12.3 EUROPE
    • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 12.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
    • 12.3.3 GERMANY
      • 12.3.3.1 Rising awareness of zoonotic diseases to fuel market growth
    • 12.3.4 UK
      • 12.3.4.1 Increasing pet ownership to stimulate demand
    • 12.3.5 FRANCE
      • 12.3.5.1 Willingness of pet owners to spend on pet health to promote market growth
    • 12.3.6 ITALY
      • 12.3.6.1 Growing consumption of meat and dairy products to drive market
    • 12.3.7 SPAIN
      • 12.3.7.1 Growing demand for poultry products to fuel market growth
    • 12.3.8 NETHERLANDS
      • 12.3.8.1 Developments in veterinary diagnostic products to support market growth
    • 12.3.9 POLAND
      • 12.3.9.1 Rapid expansion of poultry production and export-oriented farming to elevate demand
    • 12.3.10 SWEDEN
      • 12.3.10.1 Strong veterinary healthcare infrastructure and advanced animal welfare regulations to propel market
    • 12.3.11 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 12.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
    • 12.4.3 CHINA
      • 12.4.3.1 Increasing incidence of zoonotic diseases to propel market
    • 12.4.4 JAPAN
      • 12.4.4.1 Increasing pet expenditure to support market growth
    • 12.4.5 INDIA
      • 12.4.5.1 Increasing demand for dairy products to drive market
    • 12.4.6 AUSTRALIA
      • 12.4.6.1 Rise in pet ownership to support market growth
    • 12.4.7 SOUTH KOREA
      • 12.4.7.1 Rising need for specialized veterinary services to drive market
    • 12.4.8 NEW ZEALAND
      • 12.4.8.1 Focus on pet insurance to aid market
    • 12.4.9 THAILAND
      • 12.4.9.1 Growing focus on disease surveillance to drive market
    • 12.4.10 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 12.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
    • 12.5.3 BRAZIL
      • 12.5.3.1 Booming livestock industry to boost demand
    • 12.5.4 MEXICO
      • 12.5.4.1 Expanding poultry sector to support market growth
    • 12.5.5 ARGENTINA
      • 12.5.5.1 Expanding poultry production and increasing focus on disease monitoring to drive market
    • 12.5.6 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 12.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
    • 12.6.3 GCC COUNTRIES
      • 12.6.3.1 Kingdom of Saudi Arabia (KSA)
        • 12.6.3.1.1 Technology advancements in veterinary diagnostics to boost demand
      • 12.6.3.2 United Arab Emirates (UAE)
        • 12.6.3.2.1 Favorable government support for vet diagnostics to drive market
      • 12.6.3.3 Rest of GCC Countries
    • 12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022-APRIL 2026
  • 13.3 REVENUE ANALYSIS, 2021-2025
  • 13.4 MARKET SHARE ANALYSIS, 2025
    • 13.4.1 US MARKET SHARE ANALYSIS, 2025
    • 13.4.2 EUROPE MARKET SHARE ANALYSIS, 2025
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Product footprint
      • 13.5.5.4 Technology footprint
      • 13.5.5.5 Animal type footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 13.6.5.1 Detailed list of key startups/SMEs
      • 13.6.5.2 Competitive benchmarking of key startups/SMEs
  • 13.7 BRAND/PRODUCT COMPARISON
  • 13.8 R&D EXPENDITURE OF KEY PLAYERS
  • 13.9 COMPANY VALUATION AND FINANCIAL METRICS
    • 13.9.1 FINANCIAL METRICS
    • 13.9.2 COMPANY VALUATION
  • 13.10 COMPETITIVE SCENARIO
    • 13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
    • 13.10.2 DEALS
    • 13.10.3 EXPANSIONS
    • 13.10.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 IDEXX LABORATORIES, INC.
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches/Approvals/Enhancements
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 ZOETIS SERVICES LLC
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
        • 14.1.2.3.2 Expansions
        • 14.1.2.3.3 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Key strengths
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses & competitive threats
    • 14.1.3 THERMO FISHER SCIENTIFIC INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 MnM view
        • 14.1.3.3.1 Key strengths
        • 14.1.3.3.2 Strategic choices
        • 14.1.3.3.3 Weaknesses & competitive threats
    • 14.1.4 ANTECH DIAGNOSTICS, INC.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches/Approvals/Enhancements
        • 14.1.4.3.2 Expansions
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Key strengths
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses & competitive threats
    • 14.1.5 BIONOTE
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
      • 14.1.5.3 Recent developments
      • 14.1.5.4 Product launches/Approvals/Enhancements
        • 14.1.5.4.1 Deals
      • 14.1.5.5 MnM view
        • 14.1.5.5.1 Key strengths
        • 14.1.5.5.2 Strategic choices
        • 14.1.5.5.3 Weaknesses & competitive threats
    • 14.1.6 INNOVATIVE DIAGNOSTICS
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Other developments
    • 14.1.7 BIOMERIEUX
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product launches/Approvals/Enhancements
    • 14.1.8 INDICAL BIOSCIENCE GMBH
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Product launches/Approvals/Enhancements
    • 14.1.9 VIRBAC
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Deals
        • 14.1.9.3.2 Expansions
    • 14.1.10 MEGACOR DIAGNOSTIK GMBH
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Product launches/Approvals/Enhancements
    • 14.1.11 BIOGAL
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
    • 14.1.12 RING BIOTECHNOLOGY CO., LTD.
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Product launches/Approvals/Enhancements
        • 14.1.12.3.2 Other developments
    • 14.1.13 AGROLABO S.P.A.
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products offered
    • 14.1.14 ENALEES
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products offered
      • 14.1.14.3 Recent developments
        • 14.1.14.3.1 Product launches/Approvals/Enhancements
        • 14.1.14.3.2 Deals
        • 14.1.14.3.3 Expansions
        • 14.1.14.3.4 Other developments
    • 14.1.15 BIOPANDA REAGENTS LTD
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 FASSISI, GMBH
    • 14.2.2 SKYER, INC.
    • 14.2.3 GOLD STANDARD DIAGNOSTICS
    • 14.2.4 BIO-X DIAGNOSTICS S.A.
    • 14.2.5 AFFIGEN INC.
    • 14.2.6 ALVEO TECHNOLOGIES
    • 14.2.7 FLUXERGY INC.
    • 14.2.8 WOODLEY EQUIPMENT COMPANY LTD
    • 14.2.9 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
    • 14.2.10 CORIS BIOCONCEPT

15 RESEARCH METHODOLOGY

  • 15.1 RESEARCH APPROACH
  • 15.2 RESEARCH METHODOLOGY DESIGN
    • 15.2.1 SECONDARY RESEARCH
      • 15.2.1.1 Key data from secondary sources
    • 15.2.2 PRIMARY DATA
      • 15.2.2.1 Key data from primary sources
      • 15.2.2.2 Key industry insights
  • 15.3 MARKET SIZE ESTIMATION
    • 15.3.1 BOTTOM-UP APPROACH
  • 15.4 DATA TRIANGULATION
  • 15.5 MARKET SHARE ESTIMATION
  • 15.6 RESEARCH ASSUMPTIONS
  • 15.7 RESEARCH LIMITATIONS
    • 15.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 15.7.2 SCOPE-RELATED LIMITATIONS
  • 15.8 RISK ASSESSMENT

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
    • 16.3.1 PRODUCT ANALYSIS
    • 16.3.2 COMPANY INFORMATION
    • 16.3.3 GEOGRAPHIC ANALYSIS
    • 16.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    • 16.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE
    • 16.3.6 BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
    • 16.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION)
  • TABLE 3 VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (USD BILLION)
  • TABLE 5 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023-2025
  • TABLE 6 PRICING TREND OF PCR KITS, BY REGION, 2023-2025
  • TABLE 7 PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023-2025
  • TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 9 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 10 VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026-2027
  • TABLE 11 CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES
  • TABLE 12 CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION
  • TABLE 13 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION
  • TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS
  • TABLE 16 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA
  • TABLE 17 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA
  • TABLE 18 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK
  • TABLE 19 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO
  • TABLE 20 VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS
  • TABLE 21 KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS
  • TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
  • TABLE 28 KEY BUYING CRITERIA FOR TOP 3 END USERS
  • TABLE 29 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 30 VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 31 KEY PLAYERS PROVIDING CONSUMABLES
  • TABLE 32 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 34 KEY PLAYERS PROVIDING INSTRUMENTS
  • TABLE 35 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
  • TABLE 37 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 38 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS
  • TABLE 39 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 40 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK
  • TABLE 46 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 47 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 52 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 53 KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS
  • TABLE 54 IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
  • TABLE 56 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 57 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 58 PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • TABLE 64 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 71 US: KEY MACRO INDICATORS
  • TABLE 72 US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 73 US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 74 US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 75 US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 76 US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 77 US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 78 CANADA: KEY MACRO INDICATORS
  • TABLE 79 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 80 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 81 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 82 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 83 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 84 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • TABLE 86 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 88 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 90 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 91 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 92 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 93 GERMANY: KEY MACRO INDICATORS
  • TABLE 94 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 95 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 96 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 97 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 98 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 99 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 100 UK: KEY MACRO INDICATORS
  • TABLE 101 UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 102 UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 103 UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 104 UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 105 UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 106 UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 107 FRANCE: KEY MACRO INDICATORS
  • TABLE 108 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 109 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 110 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 111 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 112 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 113 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 114 ITALY: KEY MACRO INDICATORS
  • TABLE 115 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 116 ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 117 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 118 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 119 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 120 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 121 SPAIN: KEY MACRO INDICATORS
  • TABLE 122 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 123 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 124 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 125 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 126 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 127 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 128 NETHERLANDS: KEY MACRO INDICATORS
  • TABLE 129 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 130 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 131 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 132 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 133 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 134 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 135 POLAND: KEY MACRO INDICATORS
  • TABLE 136 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 137 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 138 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 139 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 140 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 141 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 142 SWEDEN: KEY MACRO INDICATORS
  • TABLE 143 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 144 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 145 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 146 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 147 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 148 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 149 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 150 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 151 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 152 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 153 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 154 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • TABLE 156 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 163 CHINA: KEY MACRO INDICATORS
  • TABLE 164 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 165 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 166 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 168 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 169 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 170 JAPAN: KEY MACRO INDICATORS
  • TABLE 171 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 172 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 174 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 176 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 177 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
  • TABLE 178 INDIA: KEY MACRO INDICATORS
  • TABLE 179 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 180 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 184 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 185 AUSTRALIA: KEY MACRO INDICATORS
  • TABLE 186 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 187 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 191 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 192 SOUTH KOREA: KEY MACRO INDICATORS
  • TABLE 193 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 194 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 198 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 199 NEW ZEALAND: KEY MACRO INDICATORS
  • TABLE 200 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 201 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 204 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 205 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 206 THAILAND: KEY MACRO INDICATORS
  • TABLE 207 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 208 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 209 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 210 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 211 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 212 THAILAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 217 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 218 REST OF ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 219 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • TABLE 220 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 221 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 222 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 223 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 224 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 226 LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 227 BRAZIL: KEY MACRO INDICATORS
  • TABLE 228 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 229 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 233 BRAZIL: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 234 MEXICO: KEY MACRO INDICATORS
  • TABLE 235 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 236 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 240 MEXICO: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 241 ARGENTINA: KEY MACRO INDICATORS
  • TABLE 242 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 243 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 245 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 246 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 247 ARGENTINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 248 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 249 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 251 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 253 REST OF LATIN AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 254 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (THOUSAND UNITS)
  • TABLE 255 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 256 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 257 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 261 MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 268 GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 269 KINGDOM OF SAUDI ARABIA (KSA): KEY MACRO INDICATORS
  • TABLE 270 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 271 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 272 KINGDOM OF SAUDI ARABIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 275 KINGDOM OF SAUDI ARABIA (KSA): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 276 UNITED ARAB EMIRATES (UAE): KEY MACRO INDICATORS
  • TABLE 277 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 278 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 282 UNITED ARAB EMIRATES (UAE): VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 283 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 284 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 288 REST OF GCC COUNTRIES: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
  • TABLE 294 REST OF MIDDLE EAST & AFRICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024-2031 (USD MILLION)
  • TABLE 295 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET
  • TABLE 296 VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 297 US VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 298 EUROPE VETERINARY POC DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 299 VETERINARY POC DIAGNOSTICS MARKET: REGION FOOTPRINT
  • TABLE 300 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
  • TABLE 301 VETERINARY POC DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 302 VETERINARY POC DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 303 VETERINARY POC DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 304 VETERINARY POC DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 305 VETERINARY POC DIAGNOSTICS MARKET: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2022-MAY 2026
  • TABLE 306 VETERINARY POC DIAGNOSTICS MARKET: DEALS, JANUARY 2022-APRIL 2026
  • TABLE 307 VETERINARY POC DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022-APRIL 2026
  • TABLE 308 VETERINARY POC DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2026
  • TABLE 309 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 310 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 311 IDEXX LABORATORIES, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 312 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 313 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 314 ZOETIS SERVICES LLC: DEALS
  • TABLE 315 ZOETIS SERVICES LLC: EXPANSIONS
  • TABLE 316 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS
  • TABLE 317 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 318 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 319 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
  • TABLE 320 ANTECH DIAGNOSTICS, INC.: PRODUCTS OFFERED
  • TABLE 321 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 322 ANTECH DIAGNOSTICS, INC.: EXPANSIONS
  • TABLE 323 BIONOTE: COMPANY OVERVIEW
  • TABLE 324 BIONOTE: PRODUCTS OFFERED
  • TABLE 325 BIONOTE: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 326 BIONOTE: DEALS
  • TABLE 327 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 328 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 329 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS
  • TABLE 330 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 331 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 332 BIOMERIEUX: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 333 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 334 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
  • TABLE 335 INDICAL BIOSCIENCE GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 336 VIRBAC: COMPANY OVERVIEW
  • TABLE 337 VIRBAC: PRODUCTS OFFERED
  • TABLE 338 VIRBAC: DEALS
  • TABLE 339 VIRBAC: EXPANSIONS
  • TABLE 340 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
  • TABLE 341 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED
  • TABLE 342 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 343 BIOGAL: COMPANY OVERVIEW
  • TABLE 344 BIOGAL: PRODUCTS OFFERED
  • TABLE 345 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 346 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 347 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 348 RING BIOTECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS
  • TABLE 349 AGROLABO S.P.A.: COMPANY OVERVIEW
  • TABLE 350 AGROLABO S.P.A.: PRODUCTS OFFERED
  • TABLE 351 ENALEES: COMPANY OVERVIEW
  • TABLE 352 ENALEES: PRODUCTS OFFERED
  • TABLE 353 ENALEES: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
  • TABLE 354 ENALEES: DEALS
  • TABLE 355 ENALEES: EXPANSIONS
  • TABLE 356 ENALEES: OTHER DEVELOPMENTS
  • TABLE 357 BIOPANDA REAGENTS LTD: COMPANY OVERVIEW
  • TABLE 358 BIOPANDA REAGENTS LTD: PRODUCTS OFFERED
  • TABLE 359 FASSISI, GMBH: COMPANY OVERVIEW
  • TABLE 360 SKYER, INC.: COMPANY OVERVIEW
  • TABLE 361 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 362 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
  • TABLE 363 AFFIGEN INC.: COMPANY OVERVIEW
  • TABLE 364 ALVEO TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 365 FLUXERGY INC.: COMPANY OVERVIEW
  • TABLE 366 WOODLEY EQUIPMENT COMPANY LTD: COMPANY OVERVIEW
  • TABLE 367 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 368 CORIS BIOCONCEPT: COMPANY OVERVIEW
  • TABLE 369 VETERINARY POC DIAGNOSTICS MARKET: ASSUMPTIONS ANALYSIS
  • TABLE 370 VETERINARY POC DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS

List of Figures

  • FIGURE 1 VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020-2025
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 8 INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH
  • FIGURE 9 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 10 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 13 VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD)
  • FIGURE 15 VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 17 VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS
  • FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 19 VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO
  • FIGURE 20 VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015-MAY 2026)
  • FIGURE 21 TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015-FEBRUARY 2026)
  • FIGURE 22 ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
  • FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS
  • FIGURE 25 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 26 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012-2030
  • FIGURE 27 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 28 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
  • FIGURE 29 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
  • FIGURE 30 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021-2025)
  • FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
  • FIGURE 33 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
  • FIGURE 34 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
  • FIGURE 35 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 36 VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 37 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 38 VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022-2025
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
  • FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 45 BIOMERIEUX: COMPANY SNAPSHOT
  • FIGURE 46 VIRBAC: COMPANY SNAPSHOT
  • FIGURE 47 VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN
  • FIGURE 48 DATA OBTAINED FROM SECONDARY SOURCES
  • FIGURE 49 PRIMARY SOURCES
  • FIGURE 50 DATA OBTAINED FROM PRIMARY SOURCES
  • FIGURE 51 EXPERT INSIGHTS
  • FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
  • FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
  • FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 55 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 57 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024)
  • FIGURE 58 VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
  • FIGURE 59 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026-2031)
  • FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 61 TOP-DOWN APPROACH
  • FIGURE 62 BOTTOM-UP APPROACH
  • FIGURE 63 MARKET DATA TRIANGULATION METHODOLOGY